Company news

Genexine, Inc. (KRX:095700) news

Genexine, Inc. news releases on 6ix. Latest, Sep 15, 2026: Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd…

View Genexine, Inc. →

Press releases & updates

Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd Combination and Achieves 6/6 Complete Responses in Triple Combination

September 15, 2026